ProSomnus First Quarter Revenue Soars 55 percent on Demand for Sleep Apnea Devices
| OSADelisted Stock | 0.47 0.00 0.00% |
About 56% of ProSomnus, Common's investor base is looking to short. The analysis of current outlook of investing in ProSomnus, Common Stock suggests that many traders are alarmed regarding ProSomnus, Common's prospects. The current market sentiment, together with ProSomnus, Common's historical and current headlines, can help investors time the market. In addition, many technical investors use ProSomnus, Common Stock stock news signals to limit their universe of possible portfolio assets.
ProSomnus, |
By Exec Edge Editorial Staff ProSomnus, Inc. , said revenue surged 55 percent in the first quarter from a year earlier. Revenue totaled 5.8 million, up from 3.7 million in the first quarter of 2022, it said in a statement. The maker of precision medical devices for the treatment of obstructive sleep apnea said
Read at finance.yahoo.com
 |
ProSomnus, Common Fundamental Analysis
We analyze ProSomnus, Common's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ProSomnus, Common using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ProSomnus, Common based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Book Value Per Share
Book Value Per Share Comparative Analysis
ProSomnus, Common is currently under evaluation in book value per share category among its peers. Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
ProSomnus, Common Stock Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with ProSomnus, Common stock to make a market-neutral strategy. Peer analysis of ProSomnus, Common could also be used in its relative valuation, which is a method of valuing ProSomnus, Common by comparing valuation metrics with similar companies.
Peers
ProSomnus, Common Related Equities
| NPCE | Neuropace | 5.11 | ||||
| LUNG | Pulmonx Corp | 3.30 | ||||
| KIDS | Orthopediatrics Corp | 2.36 | ||||
| OFIX | Orthofix Medical | 1.48 | ||||
| IRMD | Iradimed | 1.08 | ||||
| ITGR | Integer Holdings | 0.96 | ||||
| ANIK | Anika Therapeutics | 0.73 | ||||
| LIVN | LivaNova PLC | 0.12 | ||||
| AORT | Artivion | 0.07 | ||||
| CNMD | CONMED | 0.07 | ||||
| ESTA | Establishment Labs | 0.02 | ||||
| TMCI | Treace Medical | 0.25 | ||||
| CVRX | CVRx | 0.29 | ||||
| SRDX | SurModics | 0.47 | ||||
| ELMD | Electromed | 2.68 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Consideration for investing in ProSomnus, Stock
If you are still planning to invest in ProSomnus, Common Stock check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ProSomnus, Common's history and understand the potential risks before investing.
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |